Ravulizumab as an alternative for gemcitabine related trombotic microangiopathy: A case report
Thrombotic microangiopathy (TMA) is characterized by endotelial damage, microangiopathic hemolytic anemia, thrombocytopenia and organ damage, particularly renal. In Oncology, TMA can be secondary to the cancer itself or related to oncological treatments. TMA associated with gemcitabine has a poor pr...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-11-01
|
| Col·lecció: | Nefrología (English Edition) |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S201325142500135X |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|